Drug formulations in life sciences transactions
10 June 2021
Drug formulations are incredibly valuable to pharmaceutical businesses; however, they often get overlooked during transactions. This can create risk for both the seller and buyer of the assets. Our speakers covered the importance of drug formulations, the common pitfalls buyers and sellers can fall into during a transaction, whether you should assign or licence the formulation, and practical tips relating to both routes.